| Literature DB >> 32584769 |
Abstract
Your breath gives away a lot of information. Besides betraying that you've had garlic or onions for lunch, it also contains volatile organic compounds (VOCs) that provide quite telling biomarkers of disease. Building on the potential capability of VOCs to detect illness, the U.K. company Owlstone Medical is now developing a testing platform called Breath Biopsy [1] as a noninvasive diagnostic method and is collaborating with clinicians, researchers, and other biomedical companies around the world on its potential application for early detection of various cancers, respiratory illnesses, and immune diseases.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32584769 DOI: 10.1109/MPULS.2020.2993684
Source DB: PubMed Journal: IEEE Pulse ISSN: 2154-2287 Impact factor: 0.924